These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 32904710)

  • 1. A Review on Current Repurposing Drugs for the Treatment of COVID-19: Reality and Challenges.
    Hossen MS; Barek MA; Jahan N; Safiqul Islam M
    SN Compr Clin Med; 2020; 2(10):1777-1789. PubMed ID: 32904710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Effectiveness and Safety of Repurposing Drugs for the Treatment of COVID-19: Position Standing in 2021.
    Alam S; Kamal TB; Sarker MMR; Zhou JR; Rahman SMA; Mohamed IN
    Front Pharmacol; 2021; 12():659577. PubMed ID: 34220503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Scoping Insight on Potential Prophylactics, Vaccines and Therapeutic Weaponry for the Ongoing Novel Coronavirus (COVID-19) Pandemic- A Comprehensive Review.
    Dash P; Mohapatra S; Ghosh S; Nayak B
    Front Pharmacol; 2020; 11():590154. PubMed ID: 33815095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Update on Current Therapeutic Drugs Treating COVID-19.
    Wu R; Wang L; Kuo HD; Shannar A; Peter R; Chou PJ; Li S; Hudlikar R; Liu X; Liu Z; Poiani GJ; Amorosa L; Brunetti L; Kong AN
    Curr Pharmacol Rep; 2020; 6(3):56-70. PubMed ID: 32395418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Review of Treatment of Coronavirus Disease 2019 (COVID-19): Therapeutic Repurposing and Unmet Clinical Needs.
    Chen PL; Lee NY; Cia CT; Ko WC; Hsueh PR
    Front Pharmacol; 2020; 11():584956. PubMed ID: 33364959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review.
    Santos J; Brierley S; Gandhi MJ; Cohen MA; Moschella PC; Declan ABL
    Viruses; 2020 Jun; 12(7):. PubMed ID: 32629804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Present and future treatment strategies for coronavirus disease 2019.
    Elekhnawy E; Kamar AA; Sonbol F
    Futur J Pharm Sci; 2021; 7(1):84. PubMed ID: 33850936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological, molecular and pharmacological characteristics of chloroquine, hydroxychloroquine, convalescent plasma, and remdesivir for COVID-19 pandemic: A comparative analysis.
    Meo SA; Zaidi SZA; Shang T; Zhang JY; Al-Khlaiwi T; Bukhari IA; Akram J; Klonoff DC
    J King Saud Univ Sci; 2020 Oct; 32(7):3159-3166. PubMed ID: 32921965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological treatment of COVID-19: an opinion paper.
    García-Lledó A; Gómez-Pavón J; González Del Castillo J; Hernández-Sampelayo T; Martín-Delgado MC; Martín Sánchez FJ; Martínez-Sellés M; Molero García JM; Moreno Guillén S; Rodríguez-Artalejo FJ; Ruiz-Galiana J; Cantón R; De Lucas Ramos P; García-Botella A; Bouza E
    Rev Esp Quimioter; 2022 Apr; 35(2):115-130. PubMed ID: 34894208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Drug Repurposing for COVID-19 Clinical Trials Provide Very Effective Therapeutic Combinations: Lessons Learned From Major Clinical Studies.
    Chakraborty C; Sharma AR; Bhattacharya M; Agoramoorthy G; Lee SS
    Front Pharmacol; 2021; 12():704205. PubMed ID: 34867318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19: Are Experimental Drugs a Cure or Cause?
    Karahalil B; Elkama A
    Curr Drug Saf; 2022; 17(2):83-89. PubMed ID: 34315382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment Options for Severe Acute Respiratory Syndrome, Middle East Respiratory Syndrome, and Coronavirus Disease 2019: a Review of Clinical Evidence.
    Hoang T; Anh TTT
    Infect Chemother; 2020 Sep; 52(3):317-334. PubMed ID: 32869558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy in COVID-19; A narrative review for emergency providers.
    Mehta N; Mazer-Amirshahi M; Alkindi N; Pourmand A
    Am J Emerg Med; 2020 Jul; 38(7):1488-1493. PubMed ID: 32336586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology and Potential Therapeutic Candidates for COVID-19: A Poorly Understood Arena.
    Samaddar A; Grover M; Nag VL
    Front Pharmacol; 2020; 11():585888. PubMed ID: 33041830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Management of COVID-19: A Review of Pharmacological Treatment Options.
    Heustess AM; Allard MA; Thompson DK; Fasinu PS
    Pharmaceuticals (Basel); 2021 May; 14(6):. PubMed ID: 34071185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics of COVID-19 therapies.
    Takahashi T; Luzum JA; Nicol MR; Jacobson PA
    NPJ Genom Med; 2020; 5():35. PubMed ID: 32864162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential Treatment Options for COVID-19: A Comprehensive Review of Global Pharmacological Development Efforts.
    Neupane K; Ahmed Z; Pervez H; Ashraf R; Majeed A
    Cureus; 2020 Jun; 12(6):e8845. PubMed ID: 32754388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug repurposing in COVID-19: A review with past, present and future.
    Srivastava K; Singh MK
    Metabol Open; 2021 Dec; 12():100121. PubMed ID: 34462734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the treatment of novel coronavirus disease (COVID-19) with Western medicine and traditional Chinese medicine: a narrative review.
    Al-Romaima A; Liao Y; Feng J; Qin X; Qin G
    J Thorac Dis; 2020 Oct; 12(10):6054-6069. PubMed ID: 33209439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come?
    Indari O; Jakhmola S; Manivannan E; Jha HC
    Front Pharmacol; 2021; 12():632677. PubMed ID: 33762954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.